In summary, our pan-cancer analysis of CASP3 showed a statistically significant association between gene expression and clinical prognosis, DNA methylation, gene mutations, tumour microenvironment, TMB, and MSI across multiple tumours, and possibly related molecular mechanisms, with carriable outcomes depending on the tumour type. Here, CASP3 is linked to cancer.